Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands

BACKGROUND: Adverse drug reactions and medication nonadherence are well-known causes of sub-optimal disease control and worsened disease outcomes in patients who are treated for type 2 diabetes. Metformin sustained release (SR) might reduce these adverse events and improve medication adherence via a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gout-Zwart, Judith J., de Jong, Lisa A., Saptenno, Lisanne, Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248141/
https://www.ncbi.nlm.nih.gov/pubmed/31535305
http://dx.doi.org/10.1007/s41669-019-00179-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248141/
https://www.ncbi.nlm.nih.gov/pubmed/31535305
http://dx.doi.org/10.1007/s41669-019-00179-6

Ejemplares similares